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Abstract 
Viral diseases are among the main challenges in farming of Atlantic salmon (Salmo salar). The most prevalent viral dis-
eases in Norwegian salmon aquaculture are heart and skeletal muscle inflammation (HSMI) caused by Piscine orthore-
ovirus (PRV), and pancreas disease (PD) caused by Salmonid alphavirus (SAV). Both PRV and SAV target heart and 
skeletal muscles, but SAV additionally targets exocrine pancreas. PRV and SAV are often present in the same locations 
and co-infections occur, but the effect of this crosstalk on disease development has not been investigated. In the 
present experiment, the effect of a primary PRV infection on subsequent SAV infection was studied. Atlantic salmon 
were infected with PRV by cohabitation, followed by addition of SAV shedder fish 4 or 10 weeks after the initial PRV 
infection. Histopathological evaluation, monitoring of viral RNA levels and host gene expression analysis were used 
to assess disease development. Significant reduction of SAV RNA levels and of PD specific histopathological changes 
were observed in the co-infected groups compared to fish infected by SAV only. A strong correlation was found 
between histopathological development and expression of disease related genes in heart. In conclusion, experimen-
tally PRV infected salmon are less susceptible to secondary SAV infection and development of PD.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Virus infections are a continuous challenge in large-scale 
aquaculture of Atlantic salmon (Salmo salar). Environ-
mental factors, high intensity production and infectious 
agents affect both welfare and production [1–3]. The 
two most prevalent viral diseases in Norwegian Atlantic 
salmon aquaculture are heart and skeletal muscle inflam-
mation (HSMI) and pancreas disease (PD) [4]. Piscine 
orthoreovirus (PRV) is associated with HSMI, is ubiqui-
tous in sea reared Atlantic salmon in Norway and often 
detected without any signs of disease [5, 6]. Pancreas dis-
ease is caused by Salmon pancreas disease virus, more 
commonly known as Salmonid alphavirus (SAV). The two 
viral diseases have overlapping geographic distributions 
[4, 7], both target heart and skeletal muscle and may co-
infect Atlantic salmon [8–10].
PRV is a non-enveloped virus with a segmented, double 
stranded RNA genome, belonging to the genus Orthoreo-
virus in the family Reoviridae [5, 11]. Salmonid erythro-
cytes are major target cells for PRV and more than 50% 
of these cells may be infected in the peak phase of the 
infection [12]. In later stages of the infection, PRV infects 
myocytes of the heart and skeletal muscles [13]. The his-
topathological changes in heart and skeletal muscle gave 
the condition its name in the late 1990s, and later the 
association with PRV was established [5, 14].
SAV is an enveloped virus with a single-stranded posi-
tive sense RNA genome of the family Togaviridae [15]. 
Pancreas, heart and skeletal muscle are the main target 
tissues. The disease is recognized by growth retardation, 
reduced slaughter quality and increased mortality [9, 16, 
17]. Histopathological changes are characterized by acute 
necrosis of exocrine pancreas, myocardial and skeletal 
muscle necrosis with subsequent inflammation [9]. The 
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pancreatic lesions are a hallmark of PD and hence used 
for diagnostic differentiation from HSMI and cardio-
myopathy syndrome (CMS) [9]. However, PRV and SAV 
have common target tissues in heart and skeletal mus-
cles, making interactions between the two viral infections 
possible.
SAV is divided into six different phylogenetic subtypes 
[18] and subtypes 2 and 3 are present in Norwegian aqua-
culture [19, 20]. The two subtypes show approximately 
7% differences in nucleotide sequence [19], are endemi-
cally present in separate geographic areas and differ in 
virulence [20–22]. The mechanisms behind the difference 
in virulence are unknown. No stereotypical difference is 
described between subtype 2 and 3 [23]. PD outbreaks 
vary in duration, severity and accumulated mortality 
[24], indicating that factors other than SAV influences 
disease development. Interaction with other infectious 
agents may be such a factor.
Protection to a secondary virus infection induced by 
an unrelated primary virus infection has been recognized 
since the 1950s [25], and has also been described for sev-
eral viruses infecting salmonid fish [26–30]. However, the 
duration of the protection of rainbow trout to infectious 
hematopoietic necrosis after primary infection with the 
non-virulent cutthroat trout virus was found to be no 
more than 4  weeks [26]. In addition, some viral infec-
tions in terrestrial animals are shown to aggravate disease 
development of a secondary viral infection [31, 32].
The purpose of this study was to determine if a primary 
PRV infection alters the outcome of a subsequent SAV 
infection. Experimental infection trials were performed 
to compare disease development, viral kinetics and 
expression of disease associated genes between PRV-SAV 
co-infected and SAV infected fish.
Materials and methods
Fish
Sea water adapted Atlantic salmon (N  =  987) of a Sal-
moBreed strain (Bergen, Norway) were used in the study 
(VESO Vikan, Namsos, Norway). The post smolts were 
transferred to sea water two weeks before PRV challenge. 
Prior to challenge, the fish were screened and found to 
be negative for PRV, infectious pancreatic necrosis virus 
(IPNV) and SAV by reverse transcriptase (RT) qPCR. 
PRV shedders (N  =  5) sampled four weeks after PRV 
challenge were confirmed negative for Atlantic salmon 
calicivirus [33]. During the challenge trial the fish were 
kept in filtered and UV-radiated seawater (34  ‰ salin-
ity), 12  °C (±1  °C) and on 24  h light. The fish were fed 
1% of total biomass per day and starved for 24 h prior to 
handling and sampling. Before sampling, the fish were 
euthanized by bath immersion containing benzocaine 
chloride (1  g/5L water) (Apotekproduksjon AS, Oslo, 
Norway) for 5  min. The challenge trial was approved 
by the Norwegian Animal Research Authority and per-
formed in accordance with the recommendations of the 




The inoculum (consisting of pelleted blood cells) was 
collected in a previous cohabitation trial (VESO Vikan), 
i.e. the second passage in experimental fish, and origi-
nated from a Norwegian field outbreak of HSMI in 2012. 
RTqPCR was performed as earlier described [34] and a 
high level of PRV RNA was indicated (Ct 17.3, using a 
total RNA input of 100  ng in the RTqPCR). The blood 
pellet was dissolved 1:1 in PBS and stored at −80  °C. 
On Day 0 of the trial, the blood pellet and PBS solu-
tion was thawed on ice, diluted 1:2 in PBS and 0.1  mL 
of the inoculum was i.p. injected into the anesthetized 
shedders. The inoculum was confirmed negative for 
IPNV, infectious salmon anemia virus (ISAV), SAV, pis-
cine myocarditis virus (PMCV) by RTqPCR. After i.p. 
inoculation, the shedders (N = 363) were marked by adi-
pose fin removal and placed in a tank containing naïve 
fish (N = 396). Four weeks post PRV shedder introduc-
tion (WPC-PRV), the PRV shedders were removed and 
the cohabitants were distributed into four tanks. As 
displayed in Figure  1, at 4 WPC-PRV, two tanks con-
taining PRV cohabitants (N  =  80) were supplied with 
either SAV2 (N =  20) or SAV3 (N =  20) shedders (1:4 
ratio, shedder:cohabitant) starting the early co-infection. 
While the two other tanks contained PRV cohabitants 
until 10 WPC-PRV (indicated by “PRV” in Figure  1) 
and were sampled as PRV controls at 7 and 10 WPC-
PRV. At 10 WPC-PRV, the PRV cohabitants (N = 80) in 
the tanks, were supplied with SAV2 (N =  20) or SAV3 
(N  =  20) shedders, initiating the late co-infection. 
Hence, cohabitants in the early and late co-infection 
were challenged with SAV shedders 6 and 12 weeks post 
sea water transfer, respectively.
SAV challenge
Naïve fish (N = 218) were kept in a separate tank (“Naïve 
fish 2”, Figure  1). SAV2 or SAV3 shedders were i.p. 
injected with 0.1  mL of cell culture medium containing 
SAV2 or SAV3 at a concentration of 104 TCID50/mL. The 
SAV inocula were prepared as described earlier [21]. SAV 
shedders were marked by maxilla cutting. After injec-
tion, the SAV shedders were kept in separate tanks for 
four days before being introduced to the cohabitants. 
SAV2 or SAV3 shedders (N =  13) were placed in tanks 
with respective SAV subtype control tanks (N  =  52 in 
each tank) (Figure  1). Naïve fish to be i.p. injected with 
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SAV at 10 WPC-PRV were kept in a separate tank from 
4 to 10 WPC-PRV (“Naïve fish 3” in Figure 1). Time after 
introduction of SAV shedders will be referred to as weeks 
post SAV shedder introduction (WPC-SAV). Organ sam-
ples from heart on RNAlater™ (Ambion Inc., USA) and 
heparinized blood were collected from naïve fish (N = 4) 
before SAV challenge. These were confirmed negative for 
SAV and PRV by RTqPCR. Due to differences in viru-
lence and geographic distribution [21, 22], both SAV2 
and SAV3 were included in the study.
Sampling
Eight cohabitants were sampled from the PRV only and 
PRV-SAV co-infected groups, whereas six cohabitants 
were sampled from the SAV control groups at each sam-
pling. Eight fish sampled prior to PRV challenge served as 
negative controls. Weight and fork length was registered 
for all sampled cohabitants and Fulton’s condition factor 
(k-factor) was calculated (k-factor  =  weight in grams/
length in cm3 × 100).
Tissue samples for histopathological evaluation (heart, 
pyloric caeca including exocrine pancreas and red and 
white skeletal muscle including the lateral line) were col-
lected and fixed in 10% phosphate buffered formalin. 
After 24 h, the formalin was replaced with 70% ethanol 
and stored at 4 °C until further handling.
Two pieces of 2  mm3 from heart were collected on 
prefilled 1.0  mL tubes (FluidX® Ltd, UK) with 0.5  mL 
RNAlater™ for RTqPCR analysis. Heparinized blood was 
collected from the caudal vein.
Histopathology and immunohistochemistry
Samples for histopathology were processed and stained 
with hematoxylin and eosin following standard proce-
dures. The sections from heart, pyloric caeca and skeletal 
muscle were examined blind and scored for pathological 
changes in an ordinal system (0, 1, 2, and 3), based on 
Taksdal et  al. and McLoughlin et  al. [21, 35]. The scor-
ing performed in this study was modified and extended 
to include a separate score for acute myocardial necrosis 
and epicarditis as the former is a hallmark in PD develop-
ment and the latter is observed in both PD and HSMI [9]. 
The scoring criteria for exocrine pancreas, myocardial 
degeneration and inflammation, acute myocardial necro-
sis, epicarditis and inflammation in skeletal muscle are 
displayed in Additional file 1.
Immunohistochemistry for detection of PRV and SAV 
in heart tissue were performed as described earlier for 
detection of PRV [13]; polyclonal rabbit anti-σ1 serum 
(1:2500) [13] for PRV and monoclonal murine anti-E2 
(17H23) (1:2000) [36] for SAV were used as primary 
antibodies. Both were incubated overnight in a humid-
ity chamber, SAV at room temperature and PRV at 4 °C. 
Biotinylated goat anti-rabbit (1:200) and biotinylated rab-
bit anti-mouse (1:300) were used as secondary antibodies 
(Dako, Agilent Technologies, Glostrop, Denmark). Vec-
tastain ABC-AP kit (Vector, Laboratories, Burlingame, 
CA, USA) was used for visualization. Heart tissues from 
double infected fish tissues were investigated. As nega-
tive and positive controls, slides with SAV or PRV single 
infected tissues were included.
Figure 1 The co-infection challenge trial. The timeline above indicates weeks post PRV shedder introduction (WPC-PRV). Blue down arrow 
indicates transfer to sea water (SW). Yellow down arrow and yellow up arrow indicates introduction and removal, respectively, of PRV shedder fish. 
Red down arrow indicates introduction of SAV shedders. “Naïve fish 1” indicate the experimental fish before virus challenge, “Naïve fish 2” indicate 
fish dedicated to be SAV shedders and SAV controls at 4 WPC-PRV and “Naïve fish 3” indicate fish dedicated to be SAV shedders at 10 WPC-PRV. Blue 
box named “PRV cohabitation” indicates cohabitant fish exposed to 50% PRV shedders from 0 to 4 WPC-PRV. Blue box named “PRV” indicates PRV 
cohabitants from 4 to 10 WPC-PRV without PRV shedders. Boxes indicating a 6 week period of exposure to 20% SAV shedders are colored red (SAV 
only) and green (PRV-SAV). Co-infection induced at 4 WPC-PRV and 10 WPC-PRV is denoted PRV-SAV-early and PRV-SAV-late, respectively.
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RNA isolation and RTqPCR
All samples, including heparinized blood, were shipped 
cool (5–10  °C) and arrived within 24  h to the Norwe-
gian Veterinary Institute laboratory after sampling. Tis-
sue samples on RNAlater™ were placed at −20  °C until 
further analysis. A sub-sample of 200 µL from each hep-
arinized blood sample was subsequently shipped cold, 
together with heart samples on RNAlater™, to PatoGen 
AS for virus analysis.
PatoGen AS performed RNA extraction and RTqPCR 
analysis for PRV and SAV transcripts in heart and hep-
arinized blood. The RTqPCR assay targeting PRV is 
validated to ISO17025 standards and was described 
by Glover et  al. [37]. The SAV assay is validated and 
accredited to ISO17025 standards and was performed 
as described earlier [38]. Samples were defined as posi-
tive when having a PRV or SAV Ct lower than 37.0. 
Elongation factor 1α (EF1α) served as an internal refer-
ence gene [39] for all RTqPCR assays performed. PRV 
and SAV Ct values were normalized to EF1α Ct values 
(ΔCt = Cttarget − CtEF1α). After finalizing the virus analy-
ses, RNA (in RNase free H2O) extracted from heart and 
blood by PatoGen AS was shipped frozen on dry-ice, 
overnight to the NVI. RNA quantification and purity 
was determined using NanoDrop 2000 UV–Vis Spectro-
photometer (Thermo Scientific, Wilmington, DE, USA). 
Finally, 1  µL RNase Out (0.5  U/µL, Life technologies) 
was added and the RNA was stored at −80 °C until gene 
expression analysis.
For gene expression analysis, cDNA was produced 
from 600 ng total RNA using QuantiTect Reverse Tran-
scription Kit (Qiagen) according to the manufacturer’s 
instructions. Quantitative PCR was performed using 
15 ng (5 µL of 3 ng/µL) cDNA input per reaction using 
Maxima SYBR Green (Thermo Scientific) with 10 µM of 
both primers. Primers are listed in Table  1. The cycling 
conditions used were 95  °C for 10  min, then 40 cycles 
of 95  °C/15  s, 60  °C/30  s and 72  °C/30 s in a Mx3005P 
(Stratagene, La Jolla, CA, USA). A seven-point concen-
tration grade standard curve (40–0.675 ng) was run dur-
ing testing of the primer pairs.
Microarray analyses
The analyses were carried out using NOFIMA’s Atlan-
tic salmon oligonucleotide microarray SIQ-6 and bio-
informatic package STARS [40]. The platform includes 
15  k unique probes to protein encoding transcripts; 
the genes were annotated by functions (GO), pathways 
(KEGG) and custom vocabulary. Microarrays were 
manufactured by Agilent Technologies (Santa Clara, 
CA, USA) and unless indicated otherwise, the reagents 
and equipment were purchased from the same source. 
The microarray analyses were performed on RNA from 
heart tissue that was shipped overnight from NVI to 
NOFIMA on dry ice. RNA from uninfected hearts, sam-
pled at Day 0, was used as a common reference in all 
hybridizations. RNA amplification and labelling were 
performed with a Two-Color Quick Amp Labelling 
Kit and a Gene Expression Hybridization kit was used 
for fragmentation of labelled RNA. Total RNA input 
for each reaction was 500  ng. After overnight hybridi-
zation in an oven (17  h, 65  °C, rotation speed 0.01  g), 
arrays were washed with Gene Expression Wash Buffers 
1 and 2 and scanned with a GenePix 4100A (Molecu-
lar Devices, Sunnyvale, CA, USA). GenePix Pro 6.0 
was used for spot to grid alignment, assessment of spot 
quality, feature extraction and quantification. Subse-
quent data analyses were performed with STARS. After 
filtration of low quality spots flagged by GenePix, Low-
ess normalization of log2-expression ratios (ER) was 
Table 1 Primers used for gene expression analyses




Matrix metalloproteinase 13 Fwd: AGTGTCCAGCACAAATGACCT
Rev: CTCAACTGCTGATCCACTGGT
78 XM_014163130.1
Interleukin 1-receptor accessory protein-like 2 Fwd:CTGGCTGGTCAATGGGACAT
Rev: GTGGACCTGAAGTCCTCTGC
144 XM_014137694.1
Neuropeptide Y1 Fwd: GCTACCCGGTCAAACCTGAA
Rev: GGACTGTGGGAGCGTATCTG
194 XM_014178359.1
Serum amyloid A5 protein Fwd: GGTGCTAAAGACATGTGGCG
Rev: CCACTGGAACCCTGAACCAT
173 NM_001146565.1
Arginase 1 Fwd: TGGCGATGTGCCTTTGATTT
Rev: ATCCCGCGGTTGTCCTTTT
208 NM_001141316.2
Arginase 2—mitochondrial Fwd: AACACAGGGTTGTTGTCGGT
Rev: AGAGTCGAAGCTGTTCCGTG
193 XM_014211724.1
Page 5 of 16Lund et al. Vet Res  (2016) 47:107 
performed. Genes that passed the quality control in 
more than half of the samples were included in the sub-
sequent analyses. Differential expression was assessed 
by criteria: ER > 1.75-fold and p < 0.05.
Data analysis and statistics
The statistical analysis was performed using GraphPad 
Prism 7.0 (GraphPad Software inc., USA). Differences 
in viral RNA levels were calculated based on ΔCt values 
using the non-parametric Mann–Whitney unpaired rank 
test. Differences in gene transcript levels in heart tissue 
and histopathological scores between the groups were 
examined using the non-parametric Mann–Whitney 
unpaired rank test. An unpaired student t test was used 
to examine differences in k-factor and weight. Spear-
man’s rank correlation was calculated using STATA 13.1 
(StataCorp, USA), for associations between viral RNA 
levels in SAV cohabitants and histopathology score 
of acute myocardial necrosis. In addition, association 
between gene expression (ΔCt) and histopathology score 
of both myocardial degeneration and inflammation and 
acute myocardial necrosis was calculated. In all calcula-
tions of differences, a p < 0.05 was considered statistically 
significant.
Results
The cohabitant challenge experiment is displayed in 
Figure  1. Weeks post PRV shedder introduction are 
abbreviated as WPC-PRV and weeks post SAV shedder 
introduction as WPC-SAV. The challenge trial consisted 
of 4 or 10 weeks of PRV infection alone (WPC-PRV) and 
a subsequent 6-week PRV-SAV co-infection period. The 
different time-points for SAV shedder introduction, i.e. 4 
and 10 WPC-PRV, are termed early and late co-infection, 
respectively. Hence, the terms used are PRV-SAV-early 
or PRV-SAV-late. The SAV control fish were challenged 
simultaneously with the early co-infection. The results 
originate from cohabitant fish unless specified otherwise.
Mortality and growth
Mortality was low during the experiment. Three (0.76%) 
PRV infected fish died during the first 4 weeks, while one 
fish died in the PRV-SAV2-early group (1.25%) between 
4 and 10 WPC-PRV. The accumulated mortality at 6 
WPC-SAV was 2.0 and 5.7% in the SAV2 and SAV3 con-
trols, respectively. In the late co-infection there were no 
mortalities.
On Day 0, the mean weight, length and condition (k)-
factor was 105.6 g (range 70.6–160.4 g), 21.2 cm (range 
18.5–24.5 cm) and 1.09 (range 1.02–1.17), respectively. At 
the time of SAV shedder introduction, the mean weight 
at 4 WPC-PRV was 114.7  g (N =  16, PRV early group) 
and 109.3 g (N = 4, naïve fish) and at 10 WPC-PRV, the 
mean weight was 157.4  g (N =  16, PRV late group). At 
10 WPC-PRV, all groups had increased average weight 
and length. However, the mean k-factor was reduced in 
the PRV-SAV2-early (1.06), SAV2 (1.02) and SAV3 (1.02) 
groups and increased in PRV controls (1.10) and the 
PRV-SAV3-early group (1.11). The difference between the 
SAV control groups compared to the PRV controls and 
the PRV-SAV3-early group were significant (p < 0.05) at 
10 WPC-PRV. At the end of the trial, i.e. 16 WPC-PRV, 
the PRV-SAV2-late and PRV-SAV3-late groups had a 
mean k-factor of 1.17 and 1.11, respectively. Additional 
file 2 shows detailed range of weight, length and k-factor.
PRV infection kinetics
At day 0, the fish were confirmed negative for both PRV 
and SAV by RTqPCR. Successful transmission and infec-
tion of the cohabitants with PRV were confirmed by 
detection of viral RNA in blood and heart (Figures 2A–D). 
PRV was first detected in cohabitant fish at 3 WPC-
PRV and the level of PRV RNA peaked at 5 WPC-PRV 
in blood (mean Ct 14.2) and 6 WPC-PRV in heart 
(mean Ct 18.3). High PRV RNA levels were present in 
the fish until the end of the experiment at 16 WPC-PRV 
(Figures 2C and D).
Histopathological changes including epicarditis and 
myocardial degeneration and inflammation in red skele-
tal muscle were in accordance to experimentally induced 
HSMI (Additional file  3), as previously described [13]. 
There were no differences in ΔCt values of PRV RNA or 
histopathological changes between the PRV controls and 
PRV-SAV groups. Likewise, there were no differences 
between the co-infected groups when comparing ΔCt 
values of PRV transcripts except a significantly lower ΔCt 
value in PRV-SAV3-late group compared to PRV-SAV2-
late group at 12 WPC-PRV, p < 0.05 (Figures 2C and D).
SAV infection kinetics
SAV2 and SAV3 shedders were confirmed SAV positive 
by RTqPCR in heart and blood. The histopathological 
changes were characteristic for PD, i.e. loss of exo-
crine pancreatic tissue, acute myocardial necrosis and 
myocarditis.
SAV challenge at 4 WPC‑PRV (early co‑infection)
In the PRV-SAV2-early group, the levels of SAV RNA 
were significantly lower in blood at 3, 4 and 6 WPC-SAV 
compared to the SAV2 controls (p  <  0.05) and in heart 
at 4 and 6 WPC-SAV (p < 0.05). At both time points, 3/8 
fish were SAV negative in heart in the co-infected group.
The SAV RNA levels in the SAV3 control group peaked 
3 WPC-SAV, however the PRV-SAV3-early group did not 
reach the same level (Figures 3C and D). At 3 and 4 WPC-
SAV, the SAV RNA levels in blood was undetectable 
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in more than 50% of the fish in the co-infected group 
and significantly lower than in the SAV3 control group 
(p < 0.05). The SAV RNA level in heart was significantly 
lower in the co-infected fish at 4 and 6 WPC-SAV com-
pared to the SAV3 controls (p < 0.05).
SAV challenge at 10 WPC‑PRV (late co‑infection)
In the late co-infection, i.e. addition of SAV shedders at 
10 WPC-PRV, SAV RNA was first detected in the PRV-
SAV2-late group in blood and heart at 3 WPC-SAV and 
peaked at week 4 post SAV introduction, which was one 
week later than the control group (Figures 4A and B). The 
SAV RNA level in blood was significantly lower in the 
co-infected group at 3 WPC-SAV compared to the SAV 
control groups (p  <  0.05). Furthermore, the co-infected 
group had a significantly lower SAV RNA level in heart 
compared to the controls at 3 WPC-SAV (p < 0.05).
In the PRV-SAV3-late group the SAV RNA levels did not 
show the same delay as observed for the PRV-SAV2-late 
group (Figures 4C and D). SAV RNA was first detected 2 
WPC-SAV and reached peak levels 4 WPC-SAV in both 
heart and blood. However, at 3 and 4 WPC-SAV the SAV 
RNA level was significantly lower in heart in the co-
infected group (p  <  0.05). In blood, the SAV RNA level 
was significantly lower at 3 WPC-SAV in the PRV-SAV3-
late group compared to the SAV3 controls (p < 0.05).
During the co-infection, the SAV shedders also got 
infected with PRV (Figure 5). Although not significant, the 
PRV RNA levels in the SAV2 shedders after 6 WPC-SAV, 
were higher in heart when compared to SAV3 shedders.
Figure 2 PRV RNA kinetics. PRV ΔCt values (PRV Ct–EF1α Ct) in blood and heart from individual co-challenged fish (black and grey dots) and 
PRV control fish (red x) assayed by RTqPCR targeting PRV RNA segments. Red arrow indicates introduction of SAV shedders early (A, B) or late (C, D). 
Weeks post PRV shedder introduction (WPC-PRV) are indicated at the x-axis. N positive individuals (raw Ct <37.0) of total sampled fish is tabulated 
under each sub-figure. Asterisk indicates significant (p < 0.05) differences in PRV RNA levels.
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Histopathology in co‑infected groups
Histopathological scoring of changes in pancreas and 
acute myocardial necrosis showed a reduction in the co-
infected groups compared with SAV control groups (Fig-
ures  6  and 7). Using a non-parametric rank test of the 
ordinal histopathological score, changes in pancreas were 
found to be significantly lower at 4 and 6 WPC-SAV in 
both early and late co-infection compared to the SAV con-
trol groups (p < 0.05), except at 4 WPC-SAV in the PRV-
SAV3-late group (Figures  6  and 7). The PRV-SAV2-late 
group had also a significantly lower score in pancreas com-
pared to the SAV2 control group at 3 WPC-SAV (p < 0.05). 
The prevalence of acute myocardial necrosis was signifi-
cantly reduced at 4 WPC-SAV in the co-infected groups 
compared to the SAV controls (p < 0.05). At 6 WPC-SAV, 
the prevalence of acute myocardial necrosis was signifi-
cantly lower in the PRV-SAV3-late and PRV-SAV2-early 
groups compared to the SAV controls (p < 0.05). 
The SAV RNA levels (ΔCt) and histopathology score of 
acute myocardial necrosis showed a strong positive Spear-
man’s rank correlation (rs  =  0.81) in the SAV3 control 
group, p  <  0.05 (N  =  28), whereas a weaker correlation 
(rs = 0.59) was seen in the SAV2 controls, p < 0.05 (N = 28).
Immunohistochemistry (IHC) was performed on sec-
tions of heart tissue from single infected and co-infected 
fish. The fish were selected based on high viral levels 
(indicated by low Ct levels) of both viruses. The fish pre-
sented in Figure 8 were sampled 7 WPC-PRV, which for 
the SAV controls and co-infected groups correspond to 
three weeks post SAV introduction (3 WPC-SAV) in the 
early co-infection. Virus Ct values in the respective heart 
tissues are noted in Figure  8. In the SAV3 infected fish, 
sparse but distinct staining restricted to single cells was 
observed using SAV antibodies. The PRV antibodies yield 
a weak pink background color in both PRV infected and 
SAV infected heart tissues. However, distinct staining 
Figure 3 SAV RNA kinetics, early co-infection. SAV ΔCt values (SAV Ct–EF1α Ct) in blood and heart from individual co-challenged fish (black 
dots) and SAV control fish (red x) assayed by RTqPCR targeting SAV RNA segments. Red arrow indicates introduction of SAV2 shedders (A, B) or SAV3 
shedders (C, D). Weeks post SAV shedder introduction (WPC-SAV) are indicated at the x-axis. N positive individuals (raw Ct < 37.0) of total sampled 
fish is tabulated under each sub-figure. Asterisk indicates significant (p < 0.05) differences between co-challenged groups and SAV control group.
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was only observed in PRV infected heart. Staining of both 
SAV and PRV antibodies were achieved in two separate 
sections of a co-infected heart. In the co-infected heart 
tissue more diffuse staining was observed in epicard, 
interpreted as unspecific binding for both SAV and PRV 
antibodies. When staining the control tissue with PRV 
antibodies, a weak pink background color was observed. 
Additional files 4, 5 and 6 include more detailed pictures. 
The IHC demonstrates the presence of PRV and SAV in 
the same areas of a co-infected heart section. However, 
no individual cells could be defined as co-infected.
PRV‑SAV co‑infection and gene expression linked to heart 
pathology
Microarray analysis was performed on hearts sampled 
at 4 and 6 WPC-SAV from the late co-infection and dif-
ferences between the SAV3 control and PRV-SAV3-late 
group were analyzed (Table 2). Genes were selected based 
on their correlation with severity of pathological changes 
in heart induced by SAV infection, as previously reported 
[41]. To confirm the array results, RT-qPCR assays were 
run for seven selected genes, of which six showed signifi-
cant differences (Figure  9). The gene regulation relative 
to 4 WPC-PRV (set to zero) is shown in Figure 9. At this 
time point the heart appeared healthy by histopathologi-
cal evaluation. Gene expression at 4 and 6 WPC-SAV in 
both the early and the late co-infected group were com-
pared to 4 and 6 WPC-SAV in the SAV3 control group. 
Significant differences were found between PRV-SAV3-
late and SAV3 control for calsequestrin, neuropeptide 
Y-1 and interleukin 1-receptor accessory protein-like 2 
(IL1R-2) at both 4 and 6 WPC-SAV, at 4 WPC-SAV for 
mitochondrial arginase-2 and at 6 WPC-SAV for argin-
ase-1 and serum amyloid A5-protein (SAA5) (p < 0.05). 
Figure 4 SAV RNA kinetics, late co-infection. SAV ΔCt values (SAV Ct–EF1α Ct) in blood and heart from individual co-challenged fish (black 
dots) assayed by RTqPCR targeting SAV RNA segments. For illustration, SAV ΔCt values from SAV control fish (red x) obtained during the early 
co-infection, was included in the figure. Red arrow indicate introduction of SAV2 shedders (A, B) or SAV3 shedders (C, D). Weeks post SAV shedder 
introduction (WPC-SAV) are indicated at the x-axis. N positive individuals (raw Ct < 37.0) of total sampled fish is tabulated under each sub-figure. 
Asterisk indicates significant (p < 0.05) differences between co-challenged groups and SAV control fish.
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The early co-infected groups differed significantly from 
the SAV controls for IL1R-2, mitochondrial arginase-2 
and SAA5 at 4 WPC-SAV, and for calsequestrin, IL1R-
2, arginase-1 and SAA5 at 6 WPC-SAV (p  <  0.05). No 
significant differences between the groups were found for 
matrix metalloproteinase 13 (MMP13) expression.
Histopathology scores (ordinal variable 0, 1, 2 and 3) 
of myocardial degeneration and inflammation and acute 
Figure 5 PRV RNA levels in SAV2 and SAV3 shedder fish after 6 weeks in the tank with PRV infected fish. PRV ΔCt values (PRV Ct–EF1α 
Ct) assessed by RTqPCR targeting PRV RNA in blood (A) and heart (B). WPC-SAV indicates weeks post SAV2 or SAV3 shedder introduction.



















































































Figure 6 Histopathological evaluation of PRV-SAV2 co-infected fish. Histopathological scoring of PD associated changes in pancreas and 
acute necrosis in myocardium detected during the 6 week co-infection. Asterisk indicates significant (p < 0.05) differences between co-infected 
groups and SAV2 control fish. Week 0 represent uninfected control fish.
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myocardial necrosis were correlated with gene expression 
levels from the qPCR, using Spearman’s rank correlation 
(Table  3). The groups investigated (N  =  6/group) were 
PRV controls (4 and 10 WPC-PRV), PRV-SAV3-early 
and -late (4 and 6 WPC-SAV) and SAV3 controls (4 and 
6 WPC-SAV), making a total of N =  46 fish evaluated. 
Significant correlation was found for all gene expression 
levels toward the score of acute necrosis and inflam-
mation in myocardial tissue, except for MMP13 against 
inflammation (Table  3). When corrected for multiple 
comparisons by Bonferroni-adjusted significant level, 
IL1R2, neuropeptide Y-1, SAA5, mitochondrial argin-
ase-2 against necrosis and calsequestrin, IL1R-2, neuro-
peptide Y-1, arginase-1 against inflammation remained 
significant.
Discussion
This study demonstrates that a primary PRV infection 
reduces disease development of a subsequent SAV infec-
tion with either SAV2 or SAV3, as evidenced by lower 
levels of SAV RNA, less severe PD pathological lesions 
and higher condition factors in the co-infected groups. 
The lack of parallel groups must be accounted for when 
evaluating the presented results. Nevertheless, the obser-
vation of a similar reduction in disease development for 
both SAV subtypes in co-infected fish strengthens the 
validity of the results.
The most pronounced evidence of protection was a 
reduction in PD specific pathological lesions in exocrine 
pancreas. Lesions in the pancreas are a hallmark of SAV 
infection and used diagnostically for separation of PD 
and HSMI [9]. The heart is a target organ for both PRV 
and SAV, with myocarditis and epicarditis observed in 
both diseases [8, 9, 13]. This may possibly mask the pro-
tective effect on SAV induced myocarditis and epicarditis 
in this study. Cardiomyocytic necrosis is a typical patho-
logical finding of early stages of SAV infection [9], and is 
not considered a specific feature of HSMI. In our study 
we found that the early co-infected groups had a signifi-
cantly lower degree of acute myocardial necrosis com-
pared to SAV controls. A recent study indicate a possible 
difference in susceptibility to SAV infection depending 
on time following sea water transfer [42]. Therefore, we 
cannot exclude that the size of the fish and time after sea 
transfer may have an impact on the difference in protec-
tion observed between the SAV only control groups and 
the late co-infected groups in our study.
Co-detection of PRV and SAV in hearts have been shown 
by RTqPCR in farmed Atlantic salmon escapees in Norway 
[10]. Here, we demonstrate the presence of both viruses in 
Figure 7 Histopathological evaluation of PRV-SAV3 coinfected fish. Histopathological scoring of PD associated changes in pancreas and 
acute necrosis in myocardium during the 6 week co-infection. Asterisk indicates significant (p < 0.05) differences between co-infected groups and 
SAV3 control fish. Week 0 represent uninfected control fish.
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neighboring cells in heart tissue by immunohistochemistry 
along with co-detection by RTqPCR. However, since the 
protective effect was observed in pancreas which is not a 
target organ for PRV, this indicates that the PRV mediated 
protection is due to systemic responses and not to interac-
tion through co-infection in the same tissue. PRV utilizes 
erythrocytes for replication and dissemination in the fish 
[34], and the salmon erythrocytes can mount innate antivi-
ral responses after PRV infection [12, 43].
The PRV control group had a significantly higher k-fac-
tor 10 WPC-PRV compared to the SAV control groups at 
the same time point. The k-factors in the SAV2 and SAV3 
controls were lower compared to the corresponding double 
infected groups (PRV-SAV2-early and PRV-SAV3-early), 
although only significant for the PRV-SAV3-early group. 
The higher k-factor supports the observed less severe histo-
pathological changes in the co-infected groups, confirming 
the reduced impact of SAV after a preceding PRV infection.
Figure 8 Immunohistochemical detection of PRV and SAV in a co-infected heart. Sections of heart tissue from SAV infected, PRV infected 
and PRV-SAV co-infected fish were stained using polyclonal rabbit antiserum targeting PRV σ1 (left panel) and monoclonal murine anti-SAV E2 
(right panel). The fish were sampled at the same time point, 7 WPC-PRV which corresponds to 3WPC-SAV in the early co-infection. The small internal 
panels are enlargements to show specificity of the staining.
Page 12 of 16Lund et al. Vet Res  (2016) 47:107 
Our results are in accordance with previous co-infec-
tions in fish where reduced mortality was observed. Pre-
exposure of rainbow trout with either the non-virulent 
cutthroat trout virus (CTV) (Hepeviridae), chum salmon 
reovirus (CSV), or IPNV, gave a four week protection to 
a subsequent IHNV infection [26–30, 44, 45]. A similar 
effect against ISAV, lasting eight weeks, was observed 
for IPNV infected fish. However in that study the ISAV 
challenge was given intraperitoneally [46]. This indicates 
that long-lasting cross-protection between non-related 
viruses in fish is a general phenomenon, although the 
duration of protection may vary. Our study suggest an 
inhibitory effect of PRV on a secondary SAV infection 
which may last for at least 10 weeks post PRV challenge, 
and thus a longer duration of protection compared to 
other interfering virus infections reported in salmonids 
[26, 46].
Activation of the antiviral innate immune response, 
where the type 1 interferon (IFN) system is central [47, 
48], is a possible explanation for protection against 
unrelated viruses after a primary virus infection. Stud-
ies on SAV infection in cell cultures and in  vivo have 
shown upregulation of IFNα and a number of interferon 
induced genes [49, 50]. However, these studies revealed 
a complex antiviral innate response after SAV infection 
leading to reduced SAV propagation. PRV infection of 
Atlantic salmon RBC also cause strong up-regulation of 
antiviral genes of the innate immune response [43]. Two 
recent studies show that Mx expression is upregulated 
in heart tissue for 11 weeks [41], and in erythrocytes for 
at least eight weeks after PRV infection [43]. Interferon 
type I production was induced at the transcriptional 
level in erythrocytes for up to 7 weeks [43]. This suggests 
that circulating PRV infected erythrocytes could play 
an important role in the observed suppressive effect on 
SAV propagation and PD development by inducing inter-
feron-regulated antiviral responses in most organs prior 
to SAV infection [51].
Therefore, at the time of early SAV shedder introduc-
tion in our trial, i.e. at 4 WPC-PRV, an upregulation of 
innate antiviral genes is expected. A possible long lasting 
innate immune response may contribute to the protec-
tion seen during the late co-infection. SAV RNA levels 
in heart were significantly lower 6 WPC-SAV in the early 
co-infected groups compared to the SAV controls. This 
difference was not present at the same time point in the 
late co-infected hearts, which could indicate a decreased 
protection caused by a reduction of innate immunity. 
However, since fish IgM have lower specificity and anti-
gen affinity compared to mammalian serum antibod-
ies, at least up to 15 weeks post infection, a mechanism 
of low affinity polyreactive natural antibodies cannot be 
ruled out [52, 53].
A possible difference was observed between the two 
SAV subtypes in the ability to handle the consequences of 
the preceding PRV infection. The SAV2 and SAV3 RNA 
levels differed in the co-infected groups. SAV2 replicated 
more efficiently than SAV3 during the early co-infection, 
whereas the peak phase of both viruses was lost in the 
late co-infection with PRV, either by a delay (SAV2) or 
by a reduction (SAV3). There were large individual vari-
ations in levels of SAV RNA and in prevalence of SAV 
Table 2 Fold expression levels relative to naïve fish at day 0 of selected genes from microarray analysis at 4 or 6 WPC-SAV 
in PRV-SAV3-late and SAV3 control groups
Gene PRV‑SAV3‑late SAV3 control Difference p value
4 WPC-SAV
 Serum amyloid A-5 protein 2.79 4.15 −1.36 0.212
 Interleukin 1-receptor accessory protein-like 2 1.29 4.26 −2.98 0.040
 Matrix metalloproteinase 13 0.97 5.67 −4.69 0.015
 Calsequestrin 0.62 −3.02 3.63 0.003
 Neuropeptide Y-1 0.33 2.85 −2.53 0.002
 Arginase-1 0.03 −1.95 1.98 0.001
 Arginase-2, mitochondrial 0.80 2.60 −1.79 0.065
6 WPC-SAV
 Serum amyloid A-5 protein 1.67 4.98 −3.31 0.001
 Interleukin 1-receptor accessory protein-like 2 0.36 3.89 −3.53 0.001
 Matrix metalloproteinase 13 0.18 5.43 −5.25 0.001
 Calsequestrin 0.29 −1.68 1.97 0.001
 Neuropeptide Y-1 0.08 2.99 −2.91 0.001
 Arginase-1 0.01 −1.51 1.52 0.001
 Arginase-2, mitochondrial 0.11 3.17 −3.06 0.001
Page 13 of 16Lund et al. Vet Res  (2016) 47:107 
Figure 9 Expression of potential pancreas disease marker genes in heart. Fold induction or repression of genes identified as potential PD 
associated genes assessed in SAV3 infected (blue bars) and co-infected (red bars: PRV-SAV3-early, orange bars: PRV-SAV3-late) 4 or 6 weeks after 
SAV3 shedder introduction. Significant differences between SAV3 controls and co-infected groups are indicated with *p < 0.05. Boxes indicate mean 
fold change relative to mean levels at 4 WPC-PRV.
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positive fish in the co-infected groups, which makes it 
difficult to conclude if the apparent differences in SAV2 
and SAV3 kinetics show true different properties of the 
virus subtypes.
SAV RNA kinetics in the heart tissue of both SAV2 and 
SAV3 controls were similar when assessed by RTqPCR, 
which is in accordance with a previous SAV challenge 
trial where several isolates were tested [21]. An interest-
ing finding, that should be addressed in a suitable study, 
was the strong correlation between acute myocardial 
necrosis and SAV3 RNA level (rs  =  0.81) compared to 
SAV2 (rs = 0.59) in the individual infected fish. If SAV3 is 
a stronger inducer of acute myocardial necrosis, this may 
partly explain the observed higher mortality associated 
with SAV3 compared to SAV2 [21, 22, 54].
A previous study using salmon microarray and 
RTqPCR analysis have reported that changes in the 
expression levels of certain genes are specifically associ-
ated with SAV mediated pathological changes in heart 
[41]. We found a similar regulation of these genes in the 
SAV controls in our study and that the expression lev-
els of these genes were less affected in the co-challenge 
groups. This is in tune with the protective effects of 
a primary PRV infection, supporting histopathologi-
cal observations and virus kinetics. RTqPCR run on a 
selected number of genes confirmed the microarray 
results. In general, the gene expression pattern was more 
affected in the SAV controls compared to the co-infected 
group. A previous study indicated a difference in gene 
expression patterns between the two diseases [41]. Our 
study found that the expression differences between the 
co-infected and SAV3 control groups changed in line 
with score of histopathological lesions, with a strong 
correlation of neuropeptide Y-1 and arginase-1 expres-
sion to the score of myocardial degeneration and inflam-
mation. In mammals, neuropeptide Y has been shown to 
have several effects on inflammatory responses and car-
diomyopathy [55, 56]. Furthermore, expression of IL1R-
2, SAA5 and mitochondrial arginase-2 show a strong 
and significant correlation towards acute myocardial 
necrosis. Thus, genetic analysis may prove to be an addi-
tional tool for evaluation of the severity of salmon heart 
disease and tissue damage.
A peculiar finding was the secondary PRV infection 
detected in the SAV shedders who resided with the PRV 
cohabitants. This was observed in both the early and 
late co-infection. During the early co-infection, SAV2 
shedders had a higher PRV RNA level, although not sig-
nificant, in heart when compared to SAV3 shedders six 
weeks after introduction to PRV cohabitants. This may 
suggest that SAV3 yields a stronger protection against 
PRV than SAV2. A possible explanation is that SAV3, 
reported by others to be more virulent [21, 22, 54], yield a 
stronger immune response than SAV2. However, the lack 
of parallel tanks and number of fish per group (N =  6) 
must be accounted for when interpreting these results. 
The strong correlation between SAV RNA levels and 
myocardial necrosis may be a novel step towards under-
standing the observed virulence differences between the 
subtypes. An interesting observation in this perspective 
is the higher prevalence of HSMI in the geographically 
separated endemic areas of SAV2 in mid-Norway com-
pared to those of SAV3 further south [4, 7]. These field 
observations could potentially be linked to a higher pos-
sibility of cross-infection between SAV2 and PRV and 
more prevalent development of both diseases in PRV-
SAV2 dual infected fish.
Interactions between viral diseases may be part of the 
explanation for the large variation in severity described 
for SAV infections in the field [24]. PRV is found to infect 
fish in fresh water facilities and is ubiquitous in sea farms 
[6]. The protective effect in this study could affect the 
outcome of a PRV-SAV co-infection after sea transfer. In 
this study, the experimental fish had high levels of PRV 
RNA and developed HSMI. A more subtle PRV infection, 
where there is no HSMI development may cause a differ-
ence in strength and duration of the protection. Further 
research should address various field conditions when 
assessing the implications of PRV-SAV co-infection.
In conclusion, we found that a primary PRV infection 
partially protects against the outcomes of SAV infection 
and PD pathological lesions.
Table 3 Spearman’s rank correlation between gene 
expression (RTqPCR) and histopathology score of inflam-








rs p value rs p value
Matrix metalloproteinase 13 0.0301 0.8427 0.3573 0.0148
Calsequestrin −0.5284 0.0002 −0.4372 0.0024
Interleukin 1-receptor accessory 
protein-like 2
0.527 0.0002 0.7391 <0.0001
Neuropeptide Y-1 0.7049 <0.0001 0.6288 <0.0001
Serum amyloid A-5 protein 0.341 0.0204 0.7386 <0.0001
Arginase-2, mitochondrial 0.3798 0.0092 0.7135 <0.0001
Arginase-1 −0.6536 <0.0001 −0.4278 0.0030
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Additional file 1. Scoring criteria for histopathological changes. 
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brackets. Number indicates weeks post PRV challenge. PRV-SAV2/3e and 
PRV-SAV2/3l indicates early and late co-infection, respectively.
Additional file 3. Histopathology evaluation of epicarditis, pan-
creas pathology, acute necrosis in myocardium, inflammation in 
myocardium, inflammation in white and red skeletal muscle in PRV 
cohabitants. Weeks after PRV challenge is shown. Week 0 represents 
uninfected control fish.
Additional file 4. Immunohistochemistry of co-infected heart 
tissue stained using polyclonal rabbit antiserum targeting PRV σ1 
(right panel) and monoclonal murine anti-SAV E2 (left panel). The 
heart tissue had Ct values of 14.2 and 15.9 for SAV and PRV, respectively.
Additional file 5. Immunohistochemistry of SAV-infected heart 
tissue stained using polyclonal rabbit antiserum targeting PRV σ1 
(right panel) and monoclonal murine anti-SAV E2 (left panel). The 
heart tissue had a SAV Ct-value of 17.1.
Additional file 6. Immunohistochemistry of PRV infected heart 
tissue stained using polyclonal rabbit antiserum targeting PRV σ1 
(right panel) and monoclonal murine anti-SAV E2 (left panel). The 
heart tissue had a PRV Ct- value of 17.7.
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